Abstract

08Sep 2018 EFFICACY OF THORACIC PARAVERTEBRAL BLOCK ANESTHESIA IN BREAST AUGMENTATION SURGERY. Sarh Alaeed , Rahaf Mandura , Maan Kattan , Basim Alsaywid and Wesam Abuznadah. General physician, King Salman Armed Forces Hospital, Tabuk, Saudi Arabia. Ophthalmology teaching assistant, King Abdulaziz university, PGY 2 Saudi Board of Ophthalmology, Jeddah, Saudi Arabia. Anesthesia department chairman, Consultant anesthesiologist and pain physician, King Abdulaziz Medical City, Jeddah, Saudi Arabia. Pediatric Urologist and Epidemiologist, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Jeddah, Saudi Arabia. Assistant professor of vascular Surgery, College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

Highlights

  • Our clinical impression from patient medical records review was that the use of bilateral thoracic paravertebral block by a single injection of local anesthetic 0.2-0.5 ml/kg of bupivacaine given at a single site from T3 to T4 has a discernible role in controlling post-operative pain and thereafter analgesic consumption

  • The purpose of this study is to assess post-operative analgesic use in the first twenty-four hours in patients who went through thoracic paravertebral block and general anesthesia and its impact on antiemetic medication use, recovery room stays, a total duration of hospitalization and the possible hazards of the thoracic paravertebral block

  • Group A involved 32 patients who went through breast augmentation under general anesthesia alone, and group B included 28 patients who went through breast augmentation under general anesthesia with bilateral single injections at single level T3-T4 thoracic paravertebral block of 0.2-0.5% bupivacaine + epinephrine 5 mcg/ml (1:200000) before the induction of general anesthesia

Read more

Summary

Introduction

Our clinical impression from patient medical records review was that the use of bilateral thoracic paravertebral block by a single injection of local anesthetic 0.2-0.5 ml/kg of bupivacaine given at a single site from T3 to T4 has a discernible role in controlling post-operative pain and thereafter analgesic consumption. The purpose of this study is to assess post-operative analgesic use in the first twenty-four hours in patients who went through thoracic paravertebral block and general anesthesia and its impact on antiemetic medication use, recovery room stays, a total duration of hospitalization and the possible hazards of the thoracic paravertebral block.

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call